Search Results - "Sahakian, Eva"

Refine Results
  1. 1

    A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers by KODUMUDI, Krithika N, WOAN, Karrune, GILVARY, Danielle L, SAHAKIAN, Eva, SHENG WEI, DJEU, Julie Y

    Published in Clinical cancer research (15-09-2010)
    “…Myeloid-derived suppressor cells (MDSC) accumulate in tumor-bearing hosts and are associated with immune suppression. To date, there have only been few studies…”
    Get full text
    Journal Article
  2. 2

    Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies by Maharaj, Kamira, Uriepero, Angimar, Sahakian, Eva, Pinilla-Ibarz, Javier

    Published in Frontiers in immunology (01-08-2022)
    “…Regulatory T cells (Tregs) are responsible for maintaining immune homeostasis by controlling immune responses. They can be characterized by concomitant…”
    Get full text
    Journal Article
  3. 3

    Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia by Gamal, Wael, Mediavilla-Varela, Melanie, Uriepero-Palma, Angimar, Pinilla-Ibarz, Javier, Sahakian, Eva

    “…Although preclinical investigations have shown notable efficacy in solid tumor models utilizing in vitro-differentiated Th17 cells for adoptive cell therapy…”
    Get full text
    Journal Article
  4. 4

    The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells by Zemskova, Marina, Sahakian, Eva, Bashkirova, Svetlana, Lilly, Michael

    Published in The Journal of biological chemistry (25-07-2008)
    “…A defining characteristic of solid tumors is the capacity to divide aggressively and disseminate under conditions of nutrient deprivation, limited oxygen…”
    Get full text
    Journal Article
  5. 5

    Mycovirus-Containing Aspergillus flavus Alters Transcription Factors in Normal and Acute Lymphoblastic Leukemia Cells by Tebbi, Cameron K, Yan, Jiyu, Sahakian, Eva, Mediavilla-Varela, Melanie, Pinilla-Ibarz, Javier, Patel, Saumil, Rottinghaus, George E, Liu, Rachel Y, Dennison, Clare

    “…Transcription factors control genes to maintain normal hemopoiesis, and dysregulation of some factors can lead to acute lymphoblastic leukemia (ALL)…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model by Maharaj, Kamira, Powers, John J, Mediavilla-Varela, Melanie, Achille, Alex, Gamal, Wael, Quayle, Steven, Jones, Simon S, Sahakian, Eva, Pinilla-Ibarz, Javier

    Published in Frontiers in immunology (23-11-2020)
    “…Development of chronic lymphocytic leukemia (CLL) is associated with severe immune dysfunction. T-cell exhaustion, immune checkpoint upregulation, and increase…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia by Maharaj, Kamira, Sahakian, Eva, Pinilla-Ibarz, Javier

    Published in Blood advances (26-09-2017)
    “…Approved therapies that target the B-cell receptor (BCR) signaling pathway, such as ibrutinib and idelalisib, are known to show activity in chronic lymphocytic…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells by Zhong, Bin, Sallman, David A, Gilvary, Danielle L, Pernazza, Daniele, Sahakian, Eva, Fritz, Dillon, Cheng, Jin Q, Trougakos, Ioannis, Wei, Sheng, Djeu, Julie Y

    Published in Molecular cancer therapeutics (01-06-2010)
    “…Clusterin (CLU), in its cytoplasmic form, is abundant in many advanced cancers and has been established to be cytoprotective against chemotherapeutic agents…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity by FENGDONG CHENG, HONGWEI WANG, SMITH, Mitchell, JIANGUO TAO, SOTOMAYOR, Eduardo M, HORNA, Pedro, ZI WANG, SHAH, Bijal, SAHAKIAN, Eva, WOAN, Karrune V, VILLAGRA, Alejandro, PINILLA-IBARZ, Javier, SEBTI, Said

    Published in Cancer research (Chicago, Ill.) (01-09-2012)
    “…Mantle cell lymphoma (MCL) is an aggressive and incurable subtype of B-cell non-Hodgkin lymphomas. Although patients often respond initially to first-line…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? by Gamal, Wael, Sahakian, Eva, Pinilla-Ibarz, Javier

    Published in Blood advances (13-06-2023)
    “…[Display omitted] T helper 17 (Th17) cells have a prominent role in autoimmune diseases. In contrast, the nature of these cells in cancer is controversial,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease by Sweet, Kendra, Hazlehurst, Lori, Sahakian, Eva, Powers, John, Nodzon, Lisa, Kayali, Fadi, Hyland, Kelly, Nelson, Ashley, Pinilla-Ibarz, Javier

    Published in Leukemia research (01-11-2018)
    “…•Inhibition of pSTAT3 may alter the bone marrow and sensitize CML stem cells to TKI.•Ruxolitinib and nilotinib can be safely combined in patients with…”
    Get full text
    Journal Article